About Quantum-Si incorporated
Quantum-Si develops semiconductor-based protein sequencing platforms. Minimal revenue, very high beta, speculative. No dividend. Small market cap with thin options liquidity. CSP selling largely impractical due to wide spreads and low absolute premium on a very low-priced stock.
Medical Devices